Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments-Reference-Cited by-同舟云学术

Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments

Published:2023-09 Issue: Volume: Page:1-11
ISSN:2499-6564
Container-title:Journal of Gerontology and Geriatrics
language:
Short-container-title:JGG

Author:

Carannante Antonio,Attanasio Umberto,Cuomo Alessandra,Parrella Paolo,Campi Giacomo,Iengo Martina,Fiore Francesco,Cicia Lidia,Topa Ester,Poto Remo,Marone Giancarlo,Formisano Luigi,Bianco Roberto,Carlomagno Chiara,Picardi Marco,Della Corte Carminia Maria,Fasano Morena,Martinelli Erika,Napolitano Stefania,Troiani Teresa,Ferrara Nicola,Abete Pasquale,Mercurio Valentina,Tocchetti Carlo Gabriele

Publisher

Pacini Editore

Subject

Geriatrics and Gerontology,Aging

Reference76 articles.

1. Cuomo A, Mercurio V, Varricchi G, et al. Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients. ESC Hear Fail 2022;9:1666-1676. https://doi.org/10.1002/ehf2.13879

2. Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022;43:4229-4361. https://doi.org/10.1093/eurheartj/ehac244

3. Attanasio U, Pirozzi F, Poto R, et al. Oxidative stress in anticancer therapies-related cardiac dysfunction. Free Radic Biol Med 2021;169:410-415. https://doi.org/10.1016/j.freeradbiomed.2021.04.021

4. Herrmann (Chair) J, Lenihan (Co-chair) D, Armenian S, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J 2022;43:280-299. https://doi.org/10.1093/eurheartj/ehab674

5. Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med 2016;375:1457-1467. https://doi.org/10.1056/NEJMra1100265